Table 2.
Prophylaxis | Recommended | |
---|---|---|
YES | NO | |
Antibacterial | ||
PJP | ||
Antiviral | ||
HBV ( HBsAg+) | ||
HBV(HBsAg-/anti-HBc+) | ||
Antifungal |
*In specific high-risk cases should be considered.
**Selected patients with specific risk factors may be considered for aciclovir prophylaxis during the first 6 months of ibrutinib treatment.
***Both prophylactic treatment and monitoring are accepted.